Concepedia

Author

Hugo Perazzo

Fundação Oswaldo CruzORCID

Also Known As

Barbosa, Hugo Perazzo Pedroso, Guilherme Amaral Calvet, H Perazzo, H. Perazzo, Hugo Perazzo, Hugo Perazzo Pedroso Barbosa, Kwobah E.K, PERAZZO, Hugo, Perazzo, Hugo, Poynard, Thierry

118

Publications

2.1K

Citations

26

H-Index

37

Concepts

All Affiliations

Fundação Oswaldo CruzSorbonne UniversitéBiopredic (France)Assistance Publique – Hôpitaux de ParisInserm
HP

About

Hugo Perazzo is an author at Fundação Oswaldo Cruz specializing in medicine, hepatology, and hepatology fibrosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

349

2

Health Sciences

2

2

197

3

Public Health

1

1

20

4

Biomedical Engineering

1

1

175

5

Epidemiology

1

1

20

Hugo Perazzo

×

33

Publications

1.1K

Citations

21

H-Index

YearCitations

Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard

Thierry Poynard, M. Munteanu, Elena Luckina,

Journal of Hepatology

2013

175

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with <scp>NAFLD</scp> using the <scp>SAF</scp> score as histological reference

M. Munteanu, Dina Tiniakos, Quentin M. Anstee,

Alimentary Pharmacology & Therapeutics

2016

91

Prognostic value of liver fibrosis biomarkers: a meta-analysis.

Thierry Poynard, Yen Ngo, Hugo Perazzo,

PubMed

2011

79

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy

Hugo Perazzo, Sandra Wagner Cardoso, Carolyn Yanavich,

Journal of the International AIDS Society

2018

68

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)

Thierry Poynard, Julien Vergniol, Yen Ngo,

Journal of Hepatology

2014

46

Diagnostic value of serological biomarkers for detection of non‐alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV

Carolyn Yanavich, SW Cardoso, EP Nunes,

HIV Medicine

2021

39

Interobserver variability in transient elastography analysis of patients with chronic hepatitis C

Hugo Perazzo, Flávia Fernandes, Amanda Gomes,

Liver International

2014

38

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)

Helmi M’Kada, M. Munteanu, Hugo Perazzo,

Regulatory Toxicology and Pharmacology

2011

37

Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury

Maria Mikus, Kimi Drobin, Marcus Gry,

Liver International

2016

37

In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil

Hugo Perazzo, Sandra Wagner Cardoso, Maria Pia Diniz Ribeiro,

The Lancet Regional Health - Americas

2022

37

Page 1